Articles in this supplement focus on the global opioid crisis, including coverage of harm reduction approaches, health justice promotion, and lessons learned.
Resources and Tools
Building on last month’s episode about providing HIV and substance use care for people who are incarcerated, this month the Boston Medical Center Team talks with Dr.
In response to an increased risk of overdose, several communities in the U.S. are considering establishing spaces for people to use substances safely.
The COVID-19 pandemic resulted in federal policy changes related to telehealth use that allowed states to maximize access to medications for opioid use disorder (MOUD) through telehealth.
Individuals who have HIV who also use drugs experience increased age-matched morbidity and mortality in comparison with those with HIV who do not use drugs.
This package is a learning tool designed for health departments and community-based organizations newly offering syringe services programs (SSPs) with the purpose of indexing the materials needed for safer injection, what to offer at a syringe services program, and how to explain what materials a
This month’s Connecting Care episode continues the conversation about barriers to methadone treatment for patients, stigma, and what we can learn from other countries to advance policy and practice for methadone in the US.
This month’s Connecting Care episode discusses the challenges associated with entering and staying in methadone treatment programs and opportunities to improve treatment experiences for all.
Transgender people and communities, including nonbinary people, have specific needs within harm reduction programs.
A recent study published in Drug and Alcohol Dependence found evidence for racial/ethnic disparities in buprenorphine distribution across the United States.